PRESBYOND® Laser Blended Vision UK 2026: the Carl Zeiss LASIK option for reading glasses after 45

What is PRESBYOND Laser Blended Vision?

PRESBYOND® is Carl Zeiss Meditec's presbyopia-correcting LASIK platform. It is delivered with a femtosecond laser flap (typically the Zeiss VisuMax) and an MEL 90 excimer laser ablation, both planned in the CRS-Master treatment-planning software. The defining ingredient is the Laser Blended Vision profile: a customised aspheric ablation that controls spherical aberration so the depth of focus of each eye is increased before any monovision target is added. The dominant eye is corrected for distance, the non-dominant eye is targeted at about −1.25 to −1.50 dioptres of myopia, and the expanded depth-of-focus zones of the two eyes overlap in the brain to form a continuous binocular range of clear vision.

This is the central difference from traditional micro-monovision, where two ordinary distance corrections are simply offset and the brain has to suppress one eye at intermediate or near. PRESBYOND's expanded depth of focus reduces the gap each eye has to cover, which is why patients tolerate the blend faster, complain less of intermediate blur, and have better contrast sensitivity than with conventional monovision LASIK.

PRESBYOND has been in clinical use since 2009. Long-term peer-reviewed series from the developers (Reinstein, Archer and Gobbe) and from independent UK and European refractive centres consistently report binocular uncorrected distance acuity of 6/9 or better in 95 per cent and binocular uncorrected near acuity of N6 or better in 80 to 90 per cent of treated patients at one year, with patient-reported spectacle-independence rates of 95 to 97 per cent.

How PRESBYOND works: the science behind blended vision

Three things have to be engineered for PRESBYOND to deliver glasses-free vision across distance, intermediate and near:

1. Expand the depth of focus of each eye. A customised aspheric profile leaves the cornea slightly more prolate (steeper centrally) than a standard LASIK shape. This adds controlled positive spherical aberration that increases each eye's effective depth of focus by about 1.5 dioptres without the contrast loss seen in diffractive multifocal IOLs.
2. Add a small monovision offset. The dominant eye is corrected to plano (full distance) and the non-dominant eye is targeted at −1.25 to −1.50 D, which biases that eye toward intermediate and near. The offset is much smaller than traditional monovision (typically −2.00 to −2.50 D), so binocular summation and contrast are largely preserved.
3. Let the brain blend the two zones. Because both eyes have an expanded depth of focus, the in-focus zones overlap rather than abut. Cortical fusion of the overlapping image is faster and more comfortable than in conventional monovision, where the brain often has to suppress one eye for each task.

The flap is created with a femtosecond laser (typically the Zeiss VisuMax) so the underlying corneal stroma can be reshaped predictably. The MEL 90 excimer ablation is usually completed in under 60 seconds per eye. The flap is repositioned, the eye is rinsed, and lubricant drops are started immediately.

UK 2026 prices: PRESBYOND Laser Blended Vision

UK 2026 self-pay PRESBYOND fees are typically £4,800 to £6,800 for both eyes all-inclusive, with most reputable London refractive-specialist centres in the £5,200 to £6,400 band. The fee should always be quoted as an all-inclusive package. Treat any "from" price that does not include theatre, surgeon, femto laser and a year of follow-up with caution; in 2026 the true PRESBYOND day-one cost when those items are unbundled often lands much higher than the headline.

Compare directly to other premium refractive options on our refractive lens exchange price page, our premium intraocular lens price guide, our Light Adjustable Lens (RxSight LAL+) page and our ICL price page.

Who is a good candidate for PRESBYOND in 2026?

The PRESBYOND treatment range is wider than standard LASIK because the depth-of-focus profile tolerates a larger refractive error envelope:

• Age 45 to 70 with stable spectacle prescription for at least 12 months
• Sphere from about −8.50 to +5.75 dioptres with cylinder up to about 5.00 dioptres (subject to corneal thickness and topography)
• Healthy cornea — no keratoconus, ectasia or significant scarring; thinnest pachymetry and residual stromal bed within Zeiss MEL 90 limits
• Healthy ocular surface — controlled dry eye (treated meibomian gland dysfunction or blepharitis) and a stable tear film
• No visually significant cataract — if early lens changes are present, refractive lens exchange or cataract surgery with an EDOF or trifocal IOL is usually a better long-term value
• Realistic visual expectations — a small minority will still need readers for prolonged fine print or in dim restaurant lighting

Patients with progressive ocular disease (uncontrolled glaucoma, diabetic retinopathy, active uveitis), pregnant or breastfeeding women, and those who cannot tolerate the in-clinic blend simulation (see below) are not suitable for PRESBYOND. A formal refractive-specialist work-up always confirms candidacy on an individual basis.

The tolerance trial: the most important pre-op step

Approximately 5 to 10 per cent of presbyopic adults do not adapt comfortably to a binocular blend even with PRESBYOND's expanded depth of focus. Identifying these patients before surgery is the single most important pre-op step. The standard tolerance trial uses one of two approaches:

• In-clinic optical simulation — trial frames or contact lenses are fitted to the planned PRESBYOND target and the patient uses them around the consulting room and corridor for 20 to 60 minutes. Real-world tasks (reading the menu, looking at the phone, walking down a flight of stairs, looking out the window) are tested.
• One- to two-week contact-lens trial — soft contact lenses set to the PRESBYOND target are fitted and worn at home and at work. This is the gold standard and is recommended for any patient who is hesitant or who has previously tried and disliked traditional monovision contact lenses.

If the trial is comfortable, candidacy is confirmed and surgery is scheduled. If the trial is uncomfortable (persistent intermediate blur, headache, depth-perception difficulty), PRESBYOND is not pursued and alternatives (refractive lens exchange with an EDOF or trifocal IOL, or simply continuing reading glasses) are discussed. Skipping the tolerance trial is the most common single cause of regret after presbyopic refractive surgery.

What happens on the day of surgery?

PRESBYOND is a day-case bilateral procedure under topical anaesthesia. From check-in to discharge takes about two hours; the laser time itself is around 60 to 90 seconds per eye.

1. Final checks (10 minutes). Refraction, pupil size, and corneal measurements are repeated. The PRESBYOND treatment plan is loaded into the laser.
2. Anaesthetic drops and surgical preparation (10 minutes). Anaesthetic drops are instilled. The eye and surrounding skin are cleaned and a sterile drape is applied. A fine speculum holds the lids open.
3. Femtosecond flap creation (about 25 seconds per eye). The Zeiss VisuMax (or equivalent) creates a thin corneal flap using ultra-short pulses of light. There is a sensation of pressure but no pain.
4. Excimer ablation (about 25 to 60 seconds per eye). The flap is lifted, the MEL 90 excimer laser delivers the customised PRESBYOND profile, and the flap is repositioned.
5. Post-op assessment (15 minutes). Slit-lamp examination confirms the flap is well-seated. Lubricant, antibiotic and anti-inflammatory drops are started.
6. Discharge. You are sent home with sunglasses, eye shields, drops and a written aftercare plan. You must arrange transport home; you cannot drive.

Published PRESBYOND results: what the evidence says

The largest peer-reviewed PRESBYOND outcome series have been published by the developers (Reinstein, Archer and Gobbe in the Journal of Refractive Surgery) and by independent UK and European refractive-specialist centres. Across studies, headline binocular results at 12 months are remarkably consistent:

• Binocular uncorrected distance acuity 6/9 or better in approximately 95 per cent
• Binocular uncorrected intermediate acuity (computer at arm's length) of N8 or better in approximately 95 per cent
• Binocular uncorrected near acuity (N6 small print) in approximately 80 to 90 per cent
• Patient-reported spectacle-independence for the majority of daily tasks in 95 to 97 per cent
• Loss of one line of best-corrected distance acuity in 1 to 3 per cent (typically transient)
• Enhancement rate at 12 months approximately 5 to 12 per cent depending on baseline refractive error

Outcomes are best in patients with a healthy ocular surface, accurate biometry and a fully completed tolerance trial. Hyperopic (long-sighted) presbyopes typically need slightly longer to neuro-adapt than myopic (short-sighted) presbyopes but reach similar 12-month outcomes.

PRESBYOND vs refractive lens exchange (RLE) and premium IOLs

The fundamental difference: PRESBYOND reshapes the cornea, RLE replaces the natural lens with an intraocular implant (IOL). Each route has a different indication window:

• PRESBYOND is generally preferred for presbyopic patients in their mid-40s to early 60s with a clear or only minimally cataractous lens. Recovery is fast, the procedure is reversible with an enhancement, and there is no lifetime risk of lens-related complications. The trade-off is that the eye still has its natural lens, so a cataract may eventually develop and require surgery later in life.
• RLE / cataract surgery with a premium IOL (EDOF such as Vivity or Symfony, trifocal such as PanOptix or FineVision, or the adjustable RxSight Light Adjustable Lens) is generally preferred from the early 60s onward, when an early cataract is already starting to develop. RLE removes the future cataract risk in one step but commits the patient to an artificial lens with its specific dysphotopsia profile (haloes around lights at night for diffractive multifocals, slightly reduced near-zone with EDOFs).
• For patients in the gap zone (about 58 to 63), the choice depends on lens clarity (LOCS III grading on slit-lamp), pupil size, lifestyle and personal preference. We discuss the long-term economics — a PRESBYOND in your late 50s plus eventual cataract surgery in your late 70s versus a single RLE today — openly at consultation.

For lens-based options see our refractive lens exchange treatment page, our implant lens overview and our Light Adjustable Lens (RxSight LAL+) page.

PRESBYOND vs traditional monovision LASIK

Traditional monovision LASIK uses a standard ablation profile and a larger refractive offset (often −2.00 to −2.50 D in the non-dominant eye). The result is a clear distance eye and a clear near eye, but the in-focus zones do not overlap, so the brain must suppress one eye for each task. This works for some patients but is associated with reduced binocular contrast sensitivity, depth-perception issues at intermediate, and a meaningful failure-to-adapt rate of 10 to 20 per cent.

PRESBYOND's expanded depth of focus shrinks the offset to about −1.25 to −1.50 D and lets the in-focus zones overlap, so binocular fusion is preserved across the full range. Published comparative data show PRESBYOND patients have significantly better binocular contrast sensitivity, faster neuro-adaptation (median two weeks versus six weeks with traditional monovision) and a markedly lower failure-to-adapt rate (about 3 to 5 per cent versus 10 to 20 per cent with traditional monovision).

Patients who have previously tried and disliked traditional monovision contact lenses should always do a formal PRESBYOND tolerance trial; many tolerate the smaller PRESBYOND blend even when they did not tolerate full monovision.

Risks and side-effects of PRESBYOND

PRESBYOND has the safety profile of femto-LASIK plus the specific considerations of a binocular blend. The published serious complication rate is well under 1 per cent in CQC-registered units performing high volumes. The relevant risks are:

• Dry eye for the first 3 to 6 months — almost universal to some degree, settles with lubricants. Pre-treatment of meibomian gland dysfunction with warm compresses, lid hygiene and (in selected patients) IPL or LipiFlow improves the early postoperative experience.
• Glare, haloes, starbursts at night — common in the first weeks, usually settle by 3 months. The expanded-depth-of-focus profile produces less night dysphotopsia than diffractive multifocal IOLs.
• Slight loss of binocular contrast at low light — smaller than with traditional monovision but real; some patients use a single distance contact lens in the non-dominant eye for night driving.
• Need for an enhancement — 5 to 12 per cent at 12 months. Usually a flap-lift or surface re-treatment, included in most all-inclusive packages.
• Flap complications — rare with femtosecond flaps (under 0.3 per cent in published series): epithelial ingrowth, flap displacement after eye trauma, diffuse lamellar keratitis. All are treatable.
• Failure to adapt to the blend — about 3 to 5 per cent, lower if the tolerance trial is fully completed. Treated with a small distance enhancement of the non-dominant eye, which converts the patient to bilateral distance vision plus reading glasses for near.
• Microbial keratitis — rare (under 1 in 5,000 procedures in modern femto-LASIK series). Reduced by strict aseptic technique and prophylactic topical antibiotics.

PRESBYOND recovery week by week

• Day 0 (surgery day): Vision is misty for 2 to 4 hours, then steadily improves. Light sensitivity is normal; sunglasses and rest are recommended. Eye shields are worn for sleeping for 5 to 7 nights.
• Day 1: Most patients see well enough to read large print and watch TV. The first follow-up is usually at 24 hours.
• Day 2 to 7: Back to office work and screen use; phone and computer become comfortable. Distance vision continues to sharpen. Avoid eye rubbing, swimming and contact sports.
• Week 2 to 4: Driving in daylight is usually comfortable from days 3 to 7 (DVLA distance acuity standard 6/12). Night driving may have transient haloes that settle by 8 to 12 weeks. Reading small print becomes progressively more comfortable as neuro-adaptation completes.
• Month 2 to 3: Vision is essentially settled. The 3-month review confirms refractive outcome and discusses whether any small enhancement would help.
• Month 6 to 12: Final refractive outcome is documented at 12 months. Annual general eye examinations continue lifelong as for any adult.

How to choose a PRESBYOND surgeon and clinic

• GMC specialist registration in ophthalmology, with a refractive or cornea subspecialty interest and (ideally) UKISCRS membership.
• Audited PRESBYOND case volume — ask for the surgeon's personal annual PRESBYOND case numbers and 12-month enhancement rate. A high-volume PRESBYOND surgeon should be doing 100+ cases a year.
• Carl Zeiss accreditation — Carl Zeiss Meditec runs a structured PRESBYOND certification programme. A certified surgeon at a fully equipped Zeiss MEL 90 + VisuMax centre is the technical baseline.
• CQC-registered theatre with the latest report rated Good or Outstanding.
• Full tolerance trial offered — clinics that skip the trial in favour of a same-day decision should be avoided.
• Written all-inclusive quote covering consultation, diagnostics, theatre, surgeon, femto laser, drops and at least 12 months of follow-up plus a clear enhancement policy.
• Direct surgeon access for follow-up rather than a rotating optometrist team.

Frequently asked questions

How much does PRESBYOND cost in the UK in 2026?

UK 2026 self-pay PRESBYOND typically costs £4,800 to £6,800 for both eyes all-inclusive, with most reputable London refractive centres in the £5,200 to £6,400 range. The fee should cover refractive consultation, full diagnostic work-up (Pentacam, OCT, wavefront, dry-eye assessment), femtosecond flap, MEL 90 ablation, theatre, surgeon, drops and 12 months of follow-up. Most clinics offer 0% finance over 24 months, typically £200 to £285 per month subject to status.

What is the difference between PRESBYOND and standard LASIK?

Standard LASIK aims for both eyes corrected for distance and accepts that reading glasses will still be needed after about age 45. PRESBYOND uses a customised aspheric profile that expands each eye's depth of focus and a small monovision offset (about −1.25 to −1.50 D in the non-dominant eye) so the two depth-of-focus zones overlap and the brain blends them into one continuous range from reading distance to the horizon. About 95 to 97 per cent of suitable patients are spectacle-independent for the majority of daily tasks at one year.

Will I be totally free of glasses after PRESBYOND?

About 95 to 97 per cent of suitable patients are spectacle-independent for distance and intermediate, and 80 to 90 per cent are spectacle-independent for normal print (N6) at one year. A small minority still use reading glasses for prolonged fine print or in poor light. PRESBYOND does not promise zero glasses for every task; it promises a continuous binocular range of clear vision for the great majority of daily activities.

How does PRESBYOND compare to monovision LASIK?

Traditional monovision uses a larger offset (−2.00 to −2.50 D) and standard LASIK profiles, so the in-focus zones of the two eyes do not overlap and the brain has to suppress one eye for each task. This reduces binocular contrast and depth perception. PRESBYOND uses a smaller offset (−1.25 to −1.50 D) and a customised aspheric profile that expands depth of focus, so the in-focus zones overlap and the brain fuses both images. Published data show better contrast, faster adaptation (median two weeks vs six) and a much lower failure-to-adapt rate (3-5% vs 10-20%) than traditional monovision.

Should I have PRESBYOND or refractive lens exchange (RLE)?

Generally PRESBYOND is preferred for healthy presbyopic patients in their mid-40s to early 60s with a clear natural lens, and RLE with an EDOF or trifocal IOL is preferred from the early 60s onward, especially if early cataract changes are present on slit-lamp examination. The decision depends on lens clarity (LOCS III), pupil size, lifestyle, dry-eye status and personal preference. Both are discussed openly at consultation.

Can PRESBYOND be reversed if I do not like it?

PRESBYOND can be enhanced. If the blend is not tolerated, the non-dominant eye can be re-treated to plano (full distance), converting the patient to bilateral distance vision plus reading glasses for near. This is why a full tolerance trial before surgery is so important — it identifies the small minority who would not adapt and avoids the need for a reversal enhancement.

Will I still get a cataract after PRESBYOND?

Yes — PRESBYOND reshapes the cornea but does not change the natural lens, so an age-related cataract may eventually develop just as it would in untreated eyes. When that happens, cataract surgery is performed as normal. The PRESBYOND treatment is taken into account when calculating the IOL power; modern formulae handle post-LASIK biometry well, but the IOL prediction is slightly less accurate than in an unoperated eye and an enhancement may be required.

How long is the recovery after PRESBYOND?

Most patients are back to office work and screens at day 2 to 3, driving comfortably in daylight from day 3 to 7, and fully neuro-adapted to the blend at 4 to 12 weeks. Lubricant drops are used for 3 to 6 months. Final refractive outcome is documented at 12 months.

Does private medical insurance cover PRESBYOND?

No. Like all elective refractive laser surgery in the UK, PRESBYOND is treated as a self-pay procedure by Bupa, AXA, Aviva, Vitality and WPA. Most clinics offer 0% finance over 24 months as an alternative to upfront payment.

Is PRESBYOND safer than multifocal IOL implants?

The two procedures address different patients and have different risk profiles. PRESBYOND is a corneal procedure with the safety profile of femto-LASIK; the most common issues are dry eye and transient night-time haloes. Multifocal IOLs involve intraocular surgery (refractive lens exchange or cataract surgery), with rare but more serious risks (endophthalmitis, retinal detachment, cystoid macular oedema) and a known risk of permanent diffractive haloes around lights at night. PRESBYOND is usually preferred when the natural lens is still clear; lens-based options are preferred when an early cataract is already present.

Methodology and sources

This UK 2026 patient guide was prepared by the Eye Surgery Clinic editorial team and reviewed by a UK GMC-registered consultant ophthalmologist with cornea and refractive subspecialty expertise. Pricing reflects a CQC-registered London refractive sample audited against published 2024 to 2026 self-pay tariffs from the major UK refractive providers. Clinical statements are anchored on:

• Carl Zeiss Meditec PRESBYOND clinical and labelling literature, MEL 90 / VisuMax / CRS-Master technical specifications
• Reinstein DZ, Archer TJ, Gobbe M. LASIK for the correction of presbyopia — long-term outcome series in J Refract Surg
• Royal College of Ophthalmologists professional and refractive surgery standards
• UK and Ireland Society of Cataract and Refractive Surgeons (UKISCRS) guidance
• NICE Interventional Procedures Guidance on photorefractive (laser) surgery (IPG164) and related guidance
• British Contact Lens Association (BCLA) evidence-based guidance on dry eye and refractive surgery candidacy
• Care Quality Commission (CQC) inspection reports for major UK refractive units
• General Medical Council (GMC) Good Medical Practice and consent guidance

This page is editorial and educational. It is not personalised medical advice. Refractive surgery suitability can only be confirmed by an in-person ophthalmologist consultation with a full diagnostic work-up.

Book your PRESBYOND consultation

Speak directly to a UK GMC-registered consultant cornea and refractive surgeon. Same-week consultation slots are usually available. Confidential, no-obligation review of your suitability for PRESBYOND, RLE or other premium refractive options.

Related reading: Refractive lens exchange · Light Adjustable Lens (RxSight LAL+) · Premium implant lenses · ICL · About presbyopia · RLE prices